DOACS in women: pros and cons

Jan Beyer-Westendorf

doi:10.1016/S0049-3848(19)30361-5

DOACS in women: pros and cons

Jan Beyer-Westendorf^*

^*Corresponding author for this work

Comprehensive Cancer Centre

Research output: Contribution to journal › Article › peer-review

13 Citations (Scopus)

Abstract

The recent approval of direct-acting oral anticoagulants (DOAC) for long-term anticoagulation in atrial fibrillation and venous thromboembolism resulted in a rapid implementation of these new drugs into daily care. Although DOAC dosing is similar for women and men and, overall, results in comparable outcomes, sex specific issues need to be considered. This review will discuss DOAC topics specifically related to women's health, including the risks and benefits of DOAC treatment for women, the issue of abnormal uterine bleeding from DOAC and the risk and management of DOAC exposure in pregnancy.

Original language	English
Pages (from-to)	S19-S22
Journal	Thrombosis Research
Volume	181
DOIs	https://doi.org/10.1016/S0049-3848(19)30361-5
Publication status	Published - 1 Sept 2019

Keywords

Abnormal uterine bleeding
Direct oral anticoagulants
DOAC
Menorrhagia
Pregnancy

Access to Document

10.1016/S0049-3848(19)30361-5

Cite this

@article{131a1af21c5d4f0e8ec95bac960714e9,

title = "DOACS in women: pros and cons",

abstract = "The recent approval of direct-acting oral anticoagulants (DOAC) for long-term anticoagulation in atrial fibrillation and venous thromboembolism resulted in a rapid implementation of these new drugs into daily care. Although DOAC dosing is similar for women and men and, overall, results in comparable outcomes, sex specific issues need to be considered. This review will discuss DOAC topics specifically related to women's health, including the risks and benefits of DOAC treatment for women, the issue of abnormal uterine bleeding from DOAC and the risk and management of DOAC exposure in pregnancy.",

keywords = "Abnormal uterine bleeding, Direct oral anticoagulants, DOAC, Menorrhagia, Pregnancy",

author = "Jan Beyer-Westendorf",

year = "2019",

month = sep,

day = "1",

doi = "10.1016/S0049-3848(19)30361-5",

language = "English",

volume = "181",

pages = "S19--S22",

journal = "Thrombosis Research",

issn = "0049-3848",

publisher = "Elsevier Limited",

}

TY - JOUR

T1 - DOACS in women

T2 - pros and cons

AU - Beyer-Westendorf, Jan

PY - 2019/9/1

Y1 - 2019/9/1

N2 - The recent approval of direct-acting oral anticoagulants (DOAC) for long-term anticoagulation in atrial fibrillation and venous thromboembolism resulted in a rapid implementation of these new drugs into daily care. Although DOAC dosing is similar for women and men and, overall, results in comparable outcomes, sex specific issues need to be considered. This review will discuss DOAC topics specifically related to women's health, including the risks and benefits of DOAC treatment for women, the issue of abnormal uterine bleeding from DOAC and the risk and management of DOAC exposure in pregnancy.

AB - The recent approval of direct-acting oral anticoagulants (DOAC) for long-term anticoagulation in atrial fibrillation and venous thromboembolism resulted in a rapid implementation of these new drugs into daily care. Although DOAC dosing is similar for women and men and, overall, results in comparable outcomes, sex specific issues need to be considered. This review will discuss DOAC topics specifically related to women's health, including the risks and benefits of DOAC treatment for women, the issue of abnormal uterine bleeding from DOAC and the risk and management of DOAC exposure in pregnancy.

KW - Abnormal uterine bleeding

KW - Direct oral anticoagulants

KW - DOAC

KW - Menorrhagia

KW - Pregnancy

UR - http://www.scopus.com/inward/record.url?scp=85071510663&partnerID=8YFLogxK

U2 - 10.1016/S0049-3848(19)30361-5

DO - 10.1016/S0049-3848(19)30361-5

M3 - Article

C2 - 31477222

AN - SCOPUS:85071510663

SN - 0049-3848

VL - 181

SP - S19-S22

JO - Thrombosis Research

JF - Thrombosis Research

ER -

DOACS in women: pros and cons

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this